ArticleLung Cancer (Auckland, N.Z.)2019

Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers.

Jan A Stratmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.